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The ethyl acetate fraction (EAF) of tamoenju (Hibiscus surattensis L.) leaves, used as a traditional antidiabetic agent 
in Central Sulawesi, has high inhibitory activity against α-glucosidase and dipeptidyl peptidase-4 (DPP-4). The aim 
of this study was to isolate the active compound of EAF that was carried out by step gradient polarity extraction, 
then separated and purified by chromatography. The structure was identified and characterized using NMR 
spectroscopy and LC-MS. α-glucosidase inhibitory activity was evaluated using the in vitro standard α-glucosidase 
inhibition test, while DPP-4 activity was evaluated by ex vivo DPP-4 inhibitor test using rat blood serum as the 
enzyme source. IC50 values were determined by nonlinear regression curve and fit using GraphPad Prism 8 and were 
expressed as mean ± SEM. In this research, we obtained the isolated compound was identified as kaempferol, which 
was isolated for the first time from this plant. The isolate exhibited potent α-glucosidase and DPP-4 inhibition with 
IC50 values of 27.78 ± 0.86 and 7.37 ± 0.06 µg/mL, respectively. Acarbose and sitagliptin as positive control had 
IC50 values of 17.80 ± 0.27 and 25.56 ± 0.43 µg/mL, respectively. The isolate level by LC-MS was estimated to be 
182.23 mg/g isolate. Therefore, tamoenju leaves have great potential as functional foods and in the development of 
antidiabetic drugs.  
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INTRODUCTION 
There is high plant diversity in Indonesia, but there are still many plants that have not been utilized. 
Although modern medicine has developed rapidly, Indonesians have always used plants for medicinal 
purposes. Indonesia has a huge ethnic and cultural diversity. Many endemic plants found in certain areas 
are used for the treatment of various diseases by tribes in Indonesia1,2. Tamoenju (Hibiscus surattensis L.) 
is a plant found in the village of Alindau, Donggala Regency, Central Sulawesi, Indonesia (Fig.-1). 
In general, these plants, especially the leaves, are used vegetable salad3,4 and traditional medicines for 
diabetes5 and hepatitis6,7. Some countries, such as Nigeria, India, West Africa, and Tanzania, use this 
plant to treat hypertension8, urethritis and venereal diseases3, malaria, wounds, abscesses, gonorrhea, 
stomach pain, and cough9. 
Previous pharmacological studies demonstrated that crude leaf extracts possess anti-inflammatory, 
antioxidant, analgesic, and antidiarrheal activities10. The essential oil of H. surattensis L. calyces is used 
as a natural antibacterial4. In our previous research, ethyl acetate fraction (EAF) from ethanol extract (EE) 
of tamoenju plant leaves was found to exert antidiabetic effect by improving impaired glucose tolerance. 
Furthermore, EAF exhibited better inhibition of α-glucosidase compared to the crude extract, n-hexane 
 
TAMOENJU (Hibiscus surattensis L.) LEAVES                                                                                                                       
fraction (NHF), and water fraction (WF)
levels of phenolic and flavonoid compounds
activity against dipeptidyl peptidase
total flavonoid content of EAF9
type 2 diabetes mellitus, such as α
Thus, EAF was a potential fraction to be developed as an antidiabetic agent. Therefore, EAF from EE was 
selected to isolate the active compounds for further 
active compounds contained in extracts or fractions can be used for the development of antidiabetic drugs.
Based on this, we report the isolation and identification of isolated compounds from EAF. Enzymes suc
as α-glucosidase and DPP-4, which are related to insulin secretion, have been reported as new targets for 
type 2 diabetes mellitus therapy. Therefore, this study was conducted to investigate the 
DPP-4 inhibitory activities of isolate fr
mechanisms. It is studied for the first time on extracts of tamoenju plant leaves.
 
Fig.
Materials and Equipment 
Solvents were technical grade ethanol, ethyl acetate, and n
Chemicals (Bandung, Indonesia). Other chemicals and reagents for analysis were analytical grades. The 
α-glucosidase enzyme from Saccharomyces cerevisiae
D-glucopyranoside (pNPG) (CAS 3767
Acarbose (Glucobay®), Kaempferol standard (Andalas Sitawa Fitolab, Padang, Indonesia), and DPP
Spectrofluorometry Activity Assay Kit were from Sigma Aldrich, USA (Lot. 2L02K07790). The leaves 
of H. surattensis L. were collected from Alindau, Sindue Tobata, Central Sulawesi, Indonesia
August to September 2016. The leaves were identified in Herbarium Bandungense, S
Sciences and Technology, Bandung Institute of Technology, Indonesia
1791/II.CO2.2/PL/2017. The instrument used was the nuclear magnetic resonance (NMR) Agilent DD2 
spectrometer, which operates at 500 MHz (
the solvent. Chromatography column was carried out using Silica gel 60 
chromatography (TLC) plates (Merck Kieselgel 60 F254).
reagent spray 10% H2SO4 in ethanol followed with heating at 110
were measured with Waters UPLC
Corporation, Milford). Microwell plate (IWAKI Pyrex), microwell for fluorescence (
ScientificTM), and microplate reader (Tecan Infinite M200 PRO).
 
General Procedure 
The leaves were ground and macerated using 96% ethanol solvent for five days. The crude EE 
warm distilled water (1:1) to remove chlorophyll, filtered, and then partitioned 
using solvents having high polarity
EAF (20.0 g) was fractionated and isolated by gravity column chromatography on silica gel 60 to produce 
eight fractions (EAF1-8). EAF2 (997.00 mg) was subjected to column chromatography over silica gel 
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using the same eluent to produce nine subfractions (SEAF1-9). SEAF2-5 (230.00 mg) were separated on 
a column of silica gel to produce subfraction SSEAF1-25. SSEAF3-9 (136.50 mg) underwent re-
chromatography using the same method to yield IEAF1-64. IEAF34-39 were combined and dried to get 
pure compounds (17.2 mg). Chromatography was carried out by stepwise gradient elution using solvents 
of gradually increasing polarity13. The mobile phase started from n-hexane:ethyl acetate 100:0, 90:10, 
80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, and 0:100. The mobile phase was continued with 
ethyl acetate:methanol 100:0, 90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, and 0:100. 
TLC indexing was performed and observed under UV 254 nm. 
 
Detection Method 
The purity of yield compounds from the isolation was tested by single eluation TLC with three different 
eluent compositions and two-dimensional TLC. The chemical structure of the isolate was determined 
using 1D, 2D NMR (HSQC and HMBC), and liquid chromatography-mass spectroscopy (LC-MS). The 
obtained isolate was observed based on its ability to inhibit activities of α-glucosidase and DPP-4. The 
determination of the content of the isolated compound was tested using LC-MS.  
 
Alpha-glucosidase Inhibitory Assay 
The α-glucosidase inhibitory activity was determined according to the method described previously with 
minor modifications14,15,16. A mixture of 10 μL of the sample (dissolved in DMSO) and acarbose, diluted 
with phosphate buffer at various concentrations. 40 μL phosphate buffer (100 mM, pH 6.8) and 25 μL of 
a p-nitrophenyl-α-D-glucopyranoside substrate (p-NPG; 3.2 mM), was preincubated at 37°C for 10 min. 
The reaction was initiated by the addition of 25 μL of 0.08 unit/mL α-glucosidase enzyme (dissolved in 
phosphate buffer containing 0.2% bovine serum albumin) and incubated for additional 15 min at 37°C. 
The reaction stopped with the addition of 100 μL Na2CO3 (200 mM), producing p-nitrophenol. The 
inhibitory activity was estimated by measuring the absorbance of p-nitrophenol using an ELISA 
microplate reader at a wavelength of 405 nm. Individual blanks were prepared to correct background 
absorbance. Negative control was carried out in the same manner as a sample, but the sample was 
replaced by a phosphate buffer. Acarbose tablets were dissolved in phosphate buffer and 2N HCl (1:1) 
with a concentration of 1.00% (w/v). The precipitate was collected by centrifugation, and the supernatant 
up to 10 μL was added to the reaction mixture, similar to the sample. Percentage α-glucosidase inhibitory 
activity was calculated by using the following equation: 
 
Inhibition activity = (NK - B) - (S1 - S0) / (NK - B) × 100                                                                        (1) 
 
Where, NK = negative control with enzyme addition; B = blank without enzyme addition; S1 = sample 
with the addition of enzyme; S0 = blank sample without addition of enzyme. 
 
DPP-4 Inhibitory Assay 
The inhibition of DPP-4 activity was performed using commercial assay kits according to the 
manufacturer’s instructions with modification17,18. Sitagliptin was used as the standard inhibitor. DPP-4 
was gathered from the blood serum of rats (Wistar). Briefly, 40 μL of DPP-4 assay buffer, 10 μL of DPP-
4 enzyme (blood serum), and 10 μL of sample solution (in various concentrations) as the inhibitor, were 
added into the well. After pre-incubating for 10 min at 37°C, 40 μL H-Gly-Pro-AMC as the fluorogenic 
substrate was added and incubated for 30 min at 37°C. In the initial activity wells, the inhibitor was 
replaced by DPP-4 assay buffer. The fluorescence of free 7-amino-4-methyl coumarin (AMC) was 
measured using a microplate reader (excitation at 360 nm and emission at 460 nm). The parameter 
observed was the amount of fluorescence product released upon each sample test. Then, the percentage of 
inhibition was calculated. Percent DPP-4 inhibition was calculated using the formula: 
 
Inhibition activity = (IA - B) - (I - IB) / (IA – B) × 100                                                                              (2) 
 
Where, IA = initial activity without inhibitor addition; B = background without enzyme and inhibitor 
addition; I = sample as inhibitor (isolate/standard); IB = background sample as inhibitor without enzyme 
DPP-4 addition. 
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Statistical Analyses 
Data were expressed as mean ± SEM (n=3), and the IC50 values were determined by nonlinear regression 
curve and fit using GraphPad Prism 8.0.2 software. 
 
RESULTS AND DISCUSSION 
Result of Isolation and Characterization Isolated Compound 
Fractionation and isolation of EAF using silica gel column chromatography resulted in eight fractions 
(EAF1-EAF8). EAF2 was the fraction with the best spot data based on TLC. Further separation and 
purification of EAF2 were carried out with the same method. Analysis of the fractions was performed 
using TLC. Subfractions showing similar Rf values were combined. The results of isolation of EAF 
obtained from 96% EE of tamoenju leaves showed the presence of flavonol compounds. The spots 
obtained on the TLC plate with isolated compound and standard flavonoid kaempferol is shown in Fig.-2. 
n-hexane: ethyl acetate (4:6 v/v) was used as the mobile phase. 
 
Fig.-2: TLC of Standard Kaempferol (1) and Isolated Compound (2), (a) Visible light, (b) UV 254 nm 
 
The isolated compound was obtained as a yellow amorphous powder. The purity test of the isolated 
compound was carried out by one dimensional TLC evaluation using various eluents: 
chloroform:methanol (24:1), chloroform:ethyl acetate (5:2), and n-hexane:ethyl acetate (3:7) and showed 
a single spot with Rf 0.16, 0.47, and 0.81 respectively. Two dimensional TLC using two mobile phase 
composition: (1) chloroform:methanol (24:1), and (2) ethyl acetate:n-hexane (7:3). This test obtains a 
single spot indicating that the isolate was pure (Fig.-3).  
The electrospray ionization (ESI)-positive mode mass spectrum by LC-ESI-Q trap (QT)/MS showed a 
molecular ion peak at m/z 287.0599 for [M+H]+ corresponding to the molecular formula of C15H10O6 
(Fig.-4). The 1H NMR spectrum (Fig.-5) of this compound shows the proton signal of a typical flavanol 
type compound with the ABX system (6-8 ppm). For the A-ring protons, the presence of a singlet signal 
at δH 12.17 ppm means there is an -OH group in C-5. Next, a pair of aromatic proton signals at δH 6.26 
and 6.53 ppm (J = 2 Hz) are the signal protons from C-6 and C-8, thus in C-7, there is a -OH group. Two 
proton signals aromatic 2H at δH 7.02 (H-3’ and H-5’) and 8.14 ppm (H-2’ and H-6’) orthopedic coupling 
(J = 8.9 Hz) shows in-ring B has an -OH group on C-4. The 13C-NMR spectra (Fig.-6) at 94.5 (C-8); 99.2 
(C-6); 104.2 (C-10); 116.3 (C-3’ and C-5’); 123.3 (C-1’); 130.5 (C-2’ and  C-6’); 136.6 (C-3); 147.0 (C-
2); 162.3 (C-5); 160.2 (C-4’); 157.8 (C-9); 164.9 (C-7) and 176.6 (C-4). The 1H and 13C NMR values for 
all the carbons were assigned based on HSQC and HMBC correlations (Fig.-7 and Table-1). Based on the 
spectroscopic data, molecular weight data, and reference comparison19,20, the isolated compound was 
identified as kaempferol. The structure of the isolated compound is shown in Fig.-8. This is the first 
report of the compound in tamoenju plant. The determination of isolated compound levels was performed 
by LC-MS because it detects more specific compounds based on molecular weight, and the analysis time 
is short21. The level of isolates in this study was 182.23 mg/g isolate. 
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Fig.-3: One and Two Dimensional TLC under Visible Light by Eluents: (a) Chloroform:Methanol (24:1); (b) 
Chloroform:Ethyl Acetate (5:2); (c) n-Hexane:Ethyl Acetate (3:7); and (d) (1) Chloroform:Methanol (24:1), and (2) 
Ethyl Acetate:n-Hexane (7:3). The Isolate was pointed with a Blue Circle. 
 
 
    Fig.-4: Mass Spectra of the Isolated Compound 
 
Fig.-5:  Spectra 1H NMR of the Isolated Compound 
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Fig.-7: HMBC NMR Spectrum of 
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Table-1: 1H (500 MHz),13C (125 MHz), and HMBC of the Isolated Compound [d6 acetone (CD3)2CO] 
 
Fig.-8: Structure of the Isolated Compound (Kaempferol) 
 
Assay for The Antidiabetic Activity of Isolated Compound 
The goal of the treatment of DM is to achieve normal blood glucose levels. One therapeutic approach to 
reduce postprandial hyperglycemia is to slow glucose absorption by inhibiting carbohydrate hydrolyzing 
enzymes in the intestine, such as glucosidase22. α-Glucosidase is an enzyme that catalyzes the final step of 
the digestion of carbohydrates; hence α-glucosidase inhibitors are compounds that can prevent the 
metabolism of complex carbohydrates into glucose to slow the use of carbohydrates to suppress 
postprandial hyperglycemia23,24. 
DPP enzymes play a role in the conversion of glucagon-like-peptide-1 (GLP-1) to its metabolites. GLP-1 
is a peptide hormone that plays a role in the stimulation of insulin release; thus, inhibition of DPP-4 can 
regulate blood sugar levels in people with diabetes. The inhibition of GLP-1 degradation by DPP-4 
inhibitors (incretin enhancers) causes endogenous GLP-1 to remain at normal levels. Therefore, DPP-4 
inhibitors have the potential to be antidiabetic agents. Furthermore, DPP-4 inhibitors repair organ systems 
which deteriorate in diabetes type 2, making this class of drug a target for development in the treatment of 
diabetes25,26.  
There is an increasing number of studies to develop effective new α-glucosidase and DPP-4 inhibitors 
with minimal side effects, obtained from medicinal plants. This study investigated the antidiabetic activity 
of the isolated compound by determining the inhibitory activity against α-glucosidase and DPP-4 
enzymes in vitro. The effects of the isolate and acarbose concentrations on α-glucosidase activity are 
shown in Table-2. The isolate inhibited α-glucosidase with an IC50 value of 27.78 ± 0.86 μg/mL compared 
to acarbose, as a standard drug, with an IC50 of 17.80 ± 0.27 μg/mL (approximately 1:1.5) (Table-2). The 




C (δC, ppm) H (δH, ppm, J Hz) 
1 - - - 
2 147.0 - - 
3 136.6 - - 
4 176.6 - - 
5 162.3 12.17 (1H; S) - 
6 99.2 6.26 (1H; D; 2.0 Hz) 94.5; 104.2; 162.3; 164.9    
7 164.9 - - 
8 94.5 6.53 (1H; D; 2.1 Hz) 99.2; 104.2; 157.8; 164.9 
9 157.8 - - 
10 104.2 - - 
1’ 123.3 - - 
2’ 130.5 8.14 (1H; D; 8.85 Hz) 147.0; 160.2 
3’ 116.3 7.02 (1H; D; 8.9 Hz) 116.3; 123.3; 160.2 
4’ 160.2 - - 
5’ 116.3 8.14 (1H; D; 8.85 Hz) 147.0; 160.2 
6’ 130.5 7.02 (1H; D; 8.9 Hz) 116.3; 123.3; 160.2 
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IC50 values are significantly different, natural bioactive compounds may be safe for use as alternative 
medicines to manage diabetes mellitus. Several studies also showed kaempferol as an α-glucosidase 
inhibitor with different IC50 values
12,27,28. The results of this study demonstrated that kaempferol possesses 
potent α-glucosidase inhibitory activity. 
 
Table-2: Percentage Inhibitory Activity of the Isolated Compound on α‑Glucosidase Activity in Comparison with 
Acarbose (n=3) 
Sample Concentration (µg/mL) Inhibition percentage (%) IC50 (µg/mL) 
Isolate 5 29.12 ± 0.33 
27.78 ± 0.86 
 10 30.97 ± 0.47 
 20 34.45 ± 0.81 
 40 49.29 ± 0.17 
 60 50.29 ± 0.14 
 80 51.89 ± 0.37 
 100 53.56 ± 0.01 
Acarbose 2.5 21.73 ± 0.55 
17.80 ± 0.27 
 5.0 28.41 ± 0.15 
 10 35.63 ± 0.33 
 20 44.38 ± 1.07 
 40 57.43 ± 0.19 
 80 97.74 ± 0.28 
 
The isolated compounds from EAF were used to determine DPP-4 inhibitory activity compared to 
sitagliptin (positive control). The results are shown in Table-3. The highest inhibitory activity was that of 
the isolated compound with an IC50 of 7.37 ± 0.06 μg/mL, whereas sitagliptin exhibited an IC50 of 25.56 
±0.43 μg/mL. These results demonstrated that kaempferol obtained from the EAF of tamoenju leaves 
were effective in inhibiting DPP-4. Similar results were obtained by Zhao et al.29, Sarian et al.12, and Gao 
et al30, although the IC50 results obtained were slightly different due to different experimental conditions. 
This supports our conclusion that kaempferol is an active compound from the EAF of tamoenju leaves 
that have a significant DPP-4 inhibitory potential and is a potential herbal-based DPP-4 inhibitor. 
 
Table-3: Percentage Inhibitory Activity of the Isolated Compound on DPP‑4 in Comparison with Sitagliptin (n=3) 
Sample Concentration (µg/mL) Inhibition percentage (%) IC50 (µg/mL) 
Isolate 1.25 25.51 ± 0.32 
7.37 ± 0.06 
 2.5 31.85 ± 0.42 
 5 33.41 ± 0.45 
 10 82.00 ± 0.13 
 20 82.73 ± 0.02 
 40 86.74 ± 0.21 
 80 94.63 ± 0.20 
Sitagliptin 1.25 22.31 ± 1.35 
25.56 ± 0.43 
 2.5 26.53 ± 0.84 
 5 31.93 ± 0.01 
 20 42.59 ± 1.97 
 40 57.79 ± 1.77 
 200 77.73 ± 0.59 
 
CONCLUSION 
Isolation and identification of chemical compounds from the EAF demonstrated that one of the flavonoid 
compounds in the leaves of tamoenju was kaempferol. Although this compound was previously reported 
as an α-glucosidase and DPP-4 inhibitor from other plants, its presence in tamoenju (Hibiscus surattensis 
L.) leaves is reported for the first time, which will further contribute to the chemical profile of the 
compound. The leaves of this plant are a source for developing α-glucosidase and DPP-4 inhibitors. 
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